Investigational Drug Information for Acotiamide
✉ Email this page to a colleague
What is the development status for investigational drug Acotiamide?
Acotiamide is an investigational drug.
There have been 6 clinical trials for Acotiamide.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Dyspepsia, Gastritis, and [disabled in preview]. The leading clinical trial sponsors are Zeria Pharmaceutical, Astellas Pharma Inc, and Universitaire Ziekenhuizen Leuven.
Summary for Acotiamide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 99 |
| WIPO Patent Applications | 41 |
| Japanese Patent Applications | 18 |
| Clinical Trial Progress | Phase 3 (2014-03-01) |
| Vendors | 40 |
Recent Clinical Trials for Acotiamide
| Title | Sponsor | Phase |
|---|---|---|
| A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia | Zeria Pharmaceutical | Phase 3 |
| Helicobacter Pylori Eradication in Functional Dyspepsia | Sir Ganga Ram Hospital | N/A |
| Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers | Universitaire Ziekenhuizen Leuven | N/A |
Clinical Trial Summary for Acotiamide
Top disease conditions for Acotiamide
Top clinical trial sponsors for Acotiamide
US Patents for Acotiamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
